Franklin Resources Inc Provention Bio, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$3.65 - $7.3 $61,779 - $123,559
-16,926 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$3.4 - $7.88 $57,548 - $133,376
16,926 New
16,926 $124,000
Q4 2021

Feb 11, 2022
SELL
$5.59 - $7.39 $86,091 - $113,813
-15,401 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.66 - $8.33 $87,169 - $128,290
15,401 New
15,401 $98,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email